Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ).
Guangdong Kanghua Healthcare Group has announced a further delay in sending a shareholder circular related to its 2026 lease agreements, which are categorized as major and connected transactions under Hong Kong listing rules. The circular, originally expected by 30 January 2026, will now be dispatched on or before 6 February 2026 to allow additional time to finalize information, including materials from the independent board committee and independent financial adviser, potentially extending the timetable for shareholder review and approval of the lease arrangements.
The most recent analyst rating on (HK:3689) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a healthcare company incorporated as a joint stock limited company in the People’s Republic of China and listed on the Hong Kong Stock Exchange under stock code 3689. The group operates in the medical and healthcare services sector, overseen by a board comprising executive, non-executive and independent non-executive directors, and is subject to Hong Kong’s listed company regulatory and disclosure framework.
Average Trading Volume: 13,520
Technical Sentiment Signal: Sell
Current Market Cap: HK$561.8M
For an in-depth examination of 3689 stock, go to TipRanks’ Overview page.